The United Nations has estimated that fighting the HIV/AIDS pandemic inthe world's poorest countries will soon cost $9.2 billion a year, with $4.4 billion going on treatment and $4.8 billion on prevention.
The estimates, which were published ahead of the UN special session on HIV/AIDS in New York, USA, on June 25-27 (see page 17), also estimated that the cost of antiretroviral drugs would take 12.5% of the total spend in the first year, rising to 25% of the total by 2005.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze